FABP2 and Cowden disease: Clinical research in patients with CD has shown that I-FABP may have a role in both the noninvasive diagnosis and follow-up of CD since serum I-FABP levels tend to reflect mucosal damage in a more reliable and quantifiable way than other available markers and has been shown to elevate and normalize faster than other markers (11,12).